Mylan Inc, a pharmaceuticals company headquartered in Cecil Township, Pennsylvania completed a $26 million buyout of a new formulation facility in Madhya Pradesh that it picked up from India’s Unichem Laboratories. Mylan also closed on a $32.5 million deal to buy a nearly new, FDA-approved plant in India from SMS Pharmaceuticals. That plant in Vizag manufactures active pharmaceutical ingredients through finished oncology products, including injectable drugs.
Last updated: December 26th, 2025
